Journal of Pharmacology and Experimental Therapeutics: 251 (2)

November 01, 1989; Volume 251,Issue 2

You have access
Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine.
R Rozental, Y Aracava, G T Scoble, K L Swanson, S Wonnacott and E X Albuquerque

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 395-404;
You have access
Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 region of the rat hippocampus.
T L Wimpey, K E Opheim and C Chavkin

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 405-411;
You have access
Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.
E T Iwamoto

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 412-421;
You have access
D2/D1 ratio in the medial preoptic area affects copulation of male rats.
E M Hull, R K Warner, T J Bazzett, R C Eaton, J T Thompson and L L Scaletta

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 422-427;
You have access
Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion.
L D Van de Kar, M Carnes, R J Maslowski, A M Bonadonna, P A Rittenhouse, K Kunimoto, R A Piechowski and C L Bethea

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 428-434;
You have access
Pharmacokinetics of naloxone: an insight into the locus of effect on stress-ulceration.
R L Kleiman-Wexler, C G Adair and K S Ephgrave

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 435-438;
You have access
Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.
A Lasdun, S Reznik, C J Molineaux and M Orlowski

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 439-447;
You have access
Cysteine S-conjugates may act as kidney-selective prodrugs: formation of 6-mercaptopurine by the renal metabolism of S-(6-purinyl)-L-cysteine.
I Y Hwang and A A Elfarra

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 448-454;
You have access
Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
A J Bertalmio and J H Woods

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 455-460;
You have access
Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
J A Clark, L Liu, M Price, B Hersh, M Edelson and G W Pasternak

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 461-468;
You have access
Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
M A Gistrak, D Paul, E F Hahn and G W Pasternak

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 469-476;
You have access
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.
D Paul, K M Standifer, C E Inturrisi and G W Pasternak

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 477-483;
You have access
SK&F 104353: selective antagonism of peptidoleukotrine-induced changes in electrolyte transport by rat ileal mucosa in vitro.
E Elton, D C Chiossone, G P McCafferty, F M Ryan and P L Smith

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 484-489;
You have access
Pharmacologic experiments on the interaction between crotoxin and the mammalian neuromuscular junction.
S Trivedi, I I Kaiser, M Tanaka and L L Simpson

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 490-496;
You have access
Opioid-induced prejunctional inhibition of vasoconstriction in the rabbit ear artery: alpha-2 adrenoceptor activation and external calcium.
D Budai and S P Duckles

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 497-501;
You have access
Effects of Bay o 2752, a hypocholesterolemic agent, on intestinal taurocholate absorption and cholesterol esterification.
K M Harnett, C T Walsh and L H Zhang

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 502-509;
You have access
Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain.
K Raynor and T Reisine

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 510-517;
You have access
Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum.
H E Shannon and B D Sawyer

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 518-523;
You have access
Serotonin depletion potentiates gastric secretory and motor responses to vagal but not peripheral gastric stimulants.
R L Stephens, T Garrick, H Weiner and Y Taché

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 524-530;
You have access
Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid.
S H Burstein, C A Audette, S A Doyle, K Hull, S A Hunter and V Latham

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 531-535;
You have access
A mu-specific opioid peptide agonist increases excitability of pyramidal neurons in untreated and receptor up-regulated hippocampus.
A M Moudy, C J Coscia and M B Laskowski

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 536-542;
You have access
Aging does not alter brain muscarinic receptor-mediated phosphoinositide hydrolysis and its inhibition by phorbol esters, tetrodotoxin and receptor desensitization.
W Surichamorn, E A Abdallah and E E el-Fakahany

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 543-549;
You have access
Role of adenosine in the gastric blood flow response to pentagastrin in the rat.
J G Gerber and P H Guth

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 550-556;
You have access
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
T A Morinelli, J E Oatis, A K Okwu, D E Mais, P R Mayeux, A Masuda, D R Knapp and P V Halushka

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 557-562;
You have access
Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
A K Mandal, K J Kellar, E Friedman, S V Pineo, P Hamosh and R A Gillis

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 563-570;
You have access
Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
A C Uprichard, L G Chi, J M Kitzen, J J Lynch, J W Frye and B R Lucchesi

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 571-577;
You have access
Angiotensin II receptor-mediated stimulation of cytosolic-free calcium and inositol phosphates in chick myocytes.
K M Baker, H A Singer and J F Aceto

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 578-585;
You have access
The anticholinergic activity of agents indicated for urinary incontinence is an important property for effective control of bladder dysfunction.
L Noronha-Blob, V C Lowe, J S Peterson and R C Hanson

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 586-593;
You have access
Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
E K Hong and A E Takemori

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 594-598;
You have access
Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
C R Bowden and C S Marchione

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 599-605;
You have access
Development and application of a radioimmunoassay for physostigmine.
H G Meyer, B J Lukey, R T Gepp, M P McCluskey and C N Lieske

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 606-611;
You have access
Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
R J Mandel, A D Chen, D J Connor and L J Thal

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 612-619;
You have access
Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit.
R Kraemer and K M Mullane

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 620-626;
You have access
Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
J Willetts and R L Balster

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 627-633;
You have access
Influence of protein kinase C activators on vascular tone and adrenergic neuroeffector events in the isolated rat kidney.
E Sehic and K U Malik

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 634-639;
You have access
Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype.
D B Bylund and C Ray-Prenger

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 640-644;
You have access
Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
L Kerecsen and R D Bunag

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 645-649;
You have access
Amiodarone blocks calcium current in single guinea pig ventricular myocytes.
M Nishimura, C H Follmer and D H Singer

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 650-659;
You have access
Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
F J Ehlert, F M Delen, S H Yun, D J Friedman and D W Self

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 660-671;
You have access
Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
W D Atchison

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 672-678;
You have access
Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system.
M E Maragoudakis, M Sarmonika and M Panoutsacopoulou

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 679-682;
You have access
The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
C F van Bezooijen and R M van Oorschot

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 683-686;
You have access
Phorbol esters and D2-dopamine receptors.
L X Cubeddu, T W Lovenberg, I S Hoffman and R K Talmaciu

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 687-693;
You have access
Effect of synthesis inhibitors of thromboxane A2 and prostaglandin E2 on the regulation of sodium and water.
J L Reyes, E Meléndez, B A Escalante and M C Namorado

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 694-699;
You have access
Dihydropyridine calcium antagonists reduce the consumption of high-energy phosphates in the rat brain. A study using combined 31P/1H magnetic resonance spectroscopy and 31P saturation transfer.
M Rudin and A Sauter

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 700-706;
You have access
An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.
N Inatomi, H Satoh, Y Maki, N Hashimoto, Z Itoh and S Omura

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 707-712;
You have access
Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells.
C Severi, D H Coy, R T Jensen, L Boschero, M C Anania and G Delle Fave

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 713-717;
You have access
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity.
T Dennis, A Fournier, S St Pierre and R Quirion

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 718-725;
You have access
Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion.
G B Glavin

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 726-730;
You have access
Kinin antagonist does not protect against the hypotensive response to endotoxin, anaphylaxis or acute pancreatitis.
T Berg, E Schlichting, H Ishida and O A Carretero

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 731-734;
You have access
Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol.
J De Vry, I Donselaar and J M Van Ree

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 735-740;
You have access
Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
E J van Hoogdalem, C D Heijligers-Feijen, R A Mathôt, A T Wackwitz, J B van Bree, J C Verhoef, A G de Boer and D D Breimer

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 741-744;
You have access
Effect of various chemical modifiers on H+ coupled transport of cephradine via dipeptide carriers in rabbit intestinal brush-border membranes: role of histidine residues.
M Kato, H Maegawa, T Okano, K Inui and R Hori

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 745-749;
You have access
Renal handling of salicyluric acid in the isolated perfused rat kidney: evidence for accumulation in tubular cells.
P G Cox, W M Moons, F G Russel and C A van Ginneken

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 750-755;
You have access
Time- and voltage-dependent block of the delayed K+ current by quinidine in rabbit sinoatrial and atrioventricular nodes.
T Furukawa, Y Tsujimura, K Kitamura, H Tanaka and Y Habuchi

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 756-763;
You have access
Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle.
M Asano

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 764-773;
You have access
Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin.
L B Katz and D A Shriver

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 774-781;
You have access
Critical period of phenytoin teratogenic action in the sea urchin, Arbacia punctulata embryo.
S Estus and J L Blumer

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 782-789;
You have access
Identification and induction of cytochromes P450, P450IIE1 and P450IA1 in rabbit bone marrow.
G G Schnier, C L Laethem and D R Koop

Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 790-796;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals